Next Article in Journal
Integrative Genomic–Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis
Next Article in Special Issue
Type and Extent of Information on (Potentially Critical) Quality Attributes Described in European Public Assessment Reports for Adalimumab Biosimilars
Previous Article in Journal
Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects
Previous Article in Special Issue
Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria
 
 
Review

Article Versions Notes

Pharmaceuticals 2021, 14(2), 117; https://doi.org/10.3390/ph14020117
Action Date Notes Link
article xml file uploaded 4 February 2021 08:39 CET Original file -
article xml uploaded. 4 February 2021 08:39 CET Update https://www.mdpi.com/1424-8247/14/2/117/xml
article pdf uploaded. 4 February 2021 08:39 CET Version of Record https://www.mdpi.com/1424-8247/14/2/117/pdf
article supplementary file uploaded. 4 February 2021 08:39 CET - https://www.mdpi.com/1424-8247/14/2/117#supplementary
article html file updated 4 February 2021 08:40 CET Original file -
article html file updated 24 July 2022 13:59 CEST Update https://www.mdpi.com/1424-8247/14/2/117/html
Back to TopTop